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ABSTRACT
The aim of the study was to examine the potential of the principal soy
isoflavones, genistein and daidzein, or isoflavone rich soy extract to recover
pituitary castration cells in orchidectomized adult male rats in comparison
with the effects of estradiol. Two weeks post orchidectomy (Orx), animals
received estradiol-dipropionate, genistein, daidzein or soy extract subcuta-
neously for 3 weeks. Control sham-operated (So) and Orx rats received just
the vehicle. Changes in the volumes of pars distalis, of individual follicle-
stimulating hormone (FSH) and luteinizing hormone (LH) containing cells,
their volume, numerical density and number were determined by unbiased
design-based stereology. The intracellular content of bFSH and bLH was
estimated by relative intensity of fluorescence (RIF). Orchidectomy
increased all examined stereological parameters and RIF. Compared to
Orx, estradiol increased the volume of pars distalis, but reversed RIF and
all morphometric parameters of gonadotropes to the level of So rats, except
their number. Treatments with purified isoflavones and soy extract
decreased RIF to the control So level, expressing an estradiol-like effect.
However, the histological appearance and morphometrical features of gona-
dotropes did not follow this pattern. Genistein increased the volume of
pars distalis, decreased the volume density of LH-labeled cells and raised
the number of gonadotropes. Daidzein decreased the cell volume of gonado-
tropic cells but increased their number and numerical density. Soy extract
induced an increase in number and numerical density of FSH-containing
cells. Therefore, it can be concluded that soy phytoestrogens do not fully
reverse the Orx-induced changes in pituitary castration cells. Anat Rec,
00:000–000, 2018. VC 2018 Wiley Periodicals, Inc.
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Human and animal diets contain several nonsteroidal,
plant substances that mimic the effects of endogenous
estrogens, known as phytoestrogens (Ososki and
Kennelly, 2003). Isoflavones are the most common form
of phytoestrogens and the prominent dietary source is
soy. The main soy isoflavones, genistein and daidzein,
exert their effects through genomic or nongenomic path-
ways. Their polyphenolic structure enables binding to
nuclear estrogen receptors (ERs), but with weaker affin-
ity than endogenous estradiol and preferential binding
affinity for ER beta (ERb) over ER alpha (ERa) (Kuiper
et al., 1998). As selective estrogen modulators (Brzezin-
ski and Debi, 1999), they can act as estrogen-agonists or
-antagonists depending on the tissue, estrogen receptor
content and concentration of circulating endogenous
estrogens (Gruber et al., 2002). In addition to classical
ERs, isoflavones serve as ligands for the membrane form
of ER (GPER) (Mostrom and Evans, 2012). Besides their
interaction with nuclear or membrane ERs, isoflavones
can interfere with the functions of the endocrine system
by affecting sex hormone-binding globulin, enzymes
involved in steroid biosynthesis, together with inhibition
of tyrosine kinase activity and antioxidant action
(Mostrom and Evans, 2012). The effects of isoflavones in
dietary supplements are even more complex, since their
mixtures can affect numerous signaling pathways or act
on the same pathways in opposing directions.
Gonadotropes are cells in the anterior pituitary that
produce two hormones, follicle-stimulating hormone
(FSH) and luteinizing hormone (LH), to regulate the
ovary and testis. They include cells that store both gona-
dotropins (bihormonal) and cells that contain only one of
them (monohormonal) (Childs, 2006). In mammals, lev-
els of circulating FSH and LH are largely determined by
balance between stimulatory input from the hypothala-
mus, i.e. gonadotropic-releasing hormone (GnRH) and
activins, and the inhibitory effects of steroids and
inhibin (Winters and Moore, 2004). The main steroids
responsible for regulation of gonadotropin secretion in
males are testicular androgens, but it has been shown
that aromatization of testosterone to estrogen also plays
a significant role at both the pituitary and hypothalamic
level (Lindzey et al., 1998).
Numerous studies have investigated the potential
effects of soy isoflavones on pituitary gonadotropic cells,
but the data are still inconclusive, partially due to the
use of different animal models, various formulations (soy
proteins, pure isoflavones, etc), diverse doses and routes
of exposure (dietary, injection and gavage), different
stages of life (gestation, perinatal or adult) and disparate
durations of exposure. In our previous study, short-term
exposure of immature female rats to high doses of genis-
tein caused stimulation of pituitary gonadotropes simi-
larly to the effect of estradiol (Medigovic´ et al., 2012).
However, in middle-aged females exposed to endogenous
estrogen throughout life, chronic application of genistein
or daidzein had no effect on gonadotropic cell size and
intracellular hormone content (Medigovic´ et al., 2015).
Ovariectomy (Ovx) of adult females is a widely used
experimental model for examination of effects of plant
derived estrogens on gonadotropic cells, since their
potency to suppress LH secretion is an indirect measure
of alleviation of postmenopausal vasomotor functions.
This is very important for their clinical use as an alter-
native to hormone replacement therapy.
In the present study we chose adult orchidectomized
(Orx) male rats whose pituitaries had not been exposed
to high endogenous estradiol concentrations before the
beginning of the experiment. This enabled more precise
assessment of the potential estrogenic effects of genis-
tein, daidzein and soy extract on gonadotropic cells
following long-term Orx, since ambiguous actions of
endogenic sex steroids were excluded.
Orchidectomy causes hyperstimulation (Farquhar and
Rinehart, 1954) and hyperplasia (Sakuma et al., 1984) of
gonadotropes. Gonadotropic cells become enlarged and
their cell body is occupied by a large vacuole that displa-
ces the nucleus to the periphery, giving the cell resem-
blance to a signet ring. Vacuolation of the cytoplasm is
caused by the extraordinarily expanded cavity of rough
endoplasmatic reticulum and a well-developed Golgi
complex. These cells are called castration or signet ring
cells. Analysis of the hormone storage pattern demon-
strated that Orx induce an increase in the proportion of
cells expressing both FSH and LH and that up to 90% of
castration cells are bihormonal (Childs, 2006).
Recovery of castration cells is manifested by reduction
of their size and number, together with suppression of
the increase in circulating LH (Watanabe et al., 1998)
and GnRH gene expression (Spratt and Herbison, 1997).
It occurs after administration of androgens and also of
estrogens, which confirms the estrogen-sensitivity of cas-
tration cells. This makes them a suitable object for
examination of the estrogenic activity of a substance.
Therefore, the aim of this study was to examine the
potential of genistein, daidzein and soy extract to
recover castration cells after long-term Orx, by quantify-
ing changes in their morphology and intracellular hor-
mone content. To that end we have used design-based
stereology which still remains one of the pillars of quan-
titative biomedical research. To determine whether soy
isoflavones or soy extract have estrogenic or antiestro-
genic effects, treatment with estradiol-dipropionate was
used as the positive control.
MATERIAL AND METHODS
Animals and Experimental Design
All animal procedures complied with Directive 2010/
63/EU on the protection of animals used for experimen-
tal and other scientific purposes, and were approved
by the Ethical Committee for the Use of Laboratory
Animals of the Institute for Biological Research
“Sinisa Stankovic´,” University of Belgrade. All surgical
interventions were performed under anesthesia (keta-
mine hydrochloride 15 mg kg21 b.w.; Richter Pharma,
Wels, Austria), and every effort was made to minimize
suffering.
The experiments involved adult, 2-month-old male
Wistar rats, bred in the facilities of the “Sinisa
Stankovic´” Institute for Biological Research, Belgrade,
Serbia. The animals were housed in groups of two per
cage, under standard environmental conditions (a 12 h
light\dark cycle, 228C6 28C). Two weeks prior to the
start of the experiment, the rats were fed ad libitum a
soy-free diet prepared in cooperation with the Depart-
ment of Food, School of Veterinary Medicine, Belgrade,
Serbia, and INSHRA PKB, Belgrade, Serbia, according
to Picherit et al. (2000), with corn oil as the fat
source as reported previously (Trifunovic´ et al., 2014a).
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Experimental animals were bilaterally orchidectomized
(Orx) or sham-operated (So). Two weeks after surgery,
the Orx rats were divided into five groups each consist-
ing of six animals. They were subcutaneously (s.c.)
injected with: 0.625 mg kg21 b.w. of estradiol-
dipropionate (Galenika, Belgrade, Serbia; Orx1E); 30
mg kg21 b.w. of genistein (Nutraceutica, Monterenzio,
Italy; Orx1G); 30 mg kg21 b.w. of daidzein (Nutraceu-
tica, Monterenzio, Italy; Orx1D) or 30 mg kg21 b.w. of
soy extract (Nutraceutica, Monterenzio, Italy; Orx1
SOY) every day for 3 weeks. According to the manufac-
turer’s specifications, the soy extract contained 40% of
isoflavones: genistein (10%), daidzein (15%), genistin
(3%), daidzin (5%), glicitin (1%), and glicitein
(0.5%). The fifth Orx group served as the control.
Genistein, daidzein and soy extract were dissolved in a
minimal volume of absolute ethanol (0.1 mL) and then
mixed with sterile olive oil (about 0.2 mL). Each animal
was treated with 0.3 mL of this mixture. The doses of
genistein and daidzein selected for this study were cho-
sen to mimic human exposure to elevated concentrations
of isoflavones when nutritional supplements are used for
therapeutic purposes (Doerge and Sheehan, 2002). They
induced histomorphological changes of the pituitary-
adrenal axis in middle-aged (Ajdzanovic´ et al., 2009a,
2009b, 2011) and adult Orx rats (Trifunovic´ et al., 2012,
2014a, 2014b). The s.c. route of administration was cho-
sen to allow precise regulation of the dose of isoflavones,
and to avoid metabolism of dietary daidzein to equol (by
intestinal microflora), which has stronger estrogenic
properties than either genistein or daidzein (Mitchell
et al., 1998). The So and the control Orx groups received
the same volume of absolute ethanol in sterile olive oil.
Tissue Preparation and Immunohistochemistry
The pituitary glands were excised, fixed in Bouin’s
solution for 48 hr and dehydrated in increasing concen-
trations of ethanol and xylene. After embedding in His-
towax (Histolab Product AB, G€oteborg, Sweden), serial
sections of the pituitary (3-lm thick) slices were placed
on silica-coated glass slides (SuperFrost Plus, Prohosp,
Denmark) and immunohistochemically stained. Series of
sections cut through three tissue levels (dorsal, middle
and ventral portions) of the pars distalis were used for
immunohistochemical and immunofluorescence localiza-
tion of bFSH and bLH containing cells. Sections were
analyzed using light (Olympus BX-51) and confocal laser
scanning microscopes (Leica TCS SP5 II Basic, Leica
Microsystems CMS GmbH; Germany). After rehydration,
the sections were stained immunohistochemically.
Gonadotropic cells were visualized using the peroxidase
enzymatic method or immunofluorescently, as previously
described (Nestorovic´ et al., 2008; Medigovic´ et al.,
2015). In both cases rabbit anti-rat bFSH (1:300 v/v) and
rabbit anti-rat bLH polyclonal antibodies (1:500 v/v)
served as primary antibodies. Antisera to rat bFSH
(NIDDK-anti-rBetaFSH-IC1 Lot# AFP-7798 1289P) and
bLH (NIDDK-anti-rBetaLH-IC Lot# AFPC697071P)
were obtained from Dr A.F. Parlow, National Hormone
Peptide Program (NHPP), Harbor-UCLA Medical Cen-
tre, Carson, CA, USA. After washing in PBS, the sec-
tions were incubated with the secondary antibody:
polyclonal swine-anti-rabbit IgG/HRP (Dako A/S,
Glostrup, Denmark) or Alexa Fluor 488 donkey anti-
rabbit IgG (Molecular Probes, Inc., USA, 1:200). For
light microscopy antibody localization was visualized
using a 0.05% DAB liquid substrate chromogen system
(Dako A/S, Glostrup, Denmark). The sections were thor-
oughly washed under running tap water and counter-
stained with hematoxylin.
For the evaluation of intracellular bFSH and bLH pro-
tein (hormonal) contents, an Ar-ion 488-nm laser was
used for excitation of fluorescence. Confocal microscopy
images were analyzed using the Quantify option in LAS
AF Lite software (Leica Application Suite Advanced Fluo-
rescence Lite/1.7.0 build 1240, Leica Microsystems CMS
GmbH; Germany). The relative intensity of fluorescence
(RIF) in the cytoplasm of pituitary FSH- and LH-
immunolabeled cells was evaluated according to previ-
ously described procedures (Medigovic´ et al., 2015; Miler
et al., 2014; Trifunovic´ et al., 2014b; Waters and Swedlow,
2007). Briefly, the region of interest (single gonadotropic
cell) was encircled with a drawing/selection tool and
included the intense spots of the immunopositive granules
within the cytoplasm of pituitary FSH- and/or LH-
immunoreactive cells. The immunonegative nuclei,
together with two different immunonegative spots in
bFSH/bLH–immunopositive gonadotropes served as ref-
erence particles for definition of background fluorescence.
The means of both measurements were calculated and
then used to determine RIF. To calculate the RIF, the
determined average of mean value was subtracted by the
average of background fluorescence, and this was done for
every single cell. The intensity of fluorescence was deter-
mined in at least 100 FSH- and 100 LH-immunoreactive
cells per animal, in which cell nuclei were apparent.
Stereological Measurements
All stereological analyses were carried out using a work-
station comprising a microscope (Olympus BX-51)
equipped with a microcator, a motorized stage and a CCD
video camera. The whole system was controlled by the
newCAST stereological software package (VIS–Visio-
pharm Integrator System, version 3.2.7.0; Visiopharm;
Denmark). The main objectives were planachromatic 43,
403, and 1003 lenses. Control of the stage movements
and the interactive test grids and unbiased disector
frames were provided by the newCAST software package.
As the reference, the volume of pars distalis (V) was
estimated using Cavalieri’s principle (Gundersen and
Jensen, 1987). Every 20th section from each tissue block
was stained with hematoxylin-eosin and used to esti-
mate pars distalis volume. To ensure a random position
for the first section, a random number table was used.
As every 20th section from each tissue block was ana-
lyzed, a number between 1 and 20 was obtained from
the random number table for sampling the first section.
Thereafter, every 20th section from each tissue block
was analyzed to enable systematic uniform random sam-
pling. At the monitor, a final magnification of 3003
allowed easy and accurate recognition of tissue bound-
aries. The numbers of points falling within the bound-
aries of the tissue were counted and summed for the
pars distalis of the whole pituitary gland. Mean section
thickness was estimated using the block advance (BA)
method (Dorph-Petersen et al., 2001), and we found that
there was no variation from 3.0 mm, as set in the micro-
tome, i.e. there were no differences between nominal
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and true section thickness. The volume of the pars dista-
lis was then estimated as:




where a(p) is the area associated with each sampling
point; BA, the block advance, is the mean distance
between two consecutively studied sections (60 mm); n is
the number of sections studied for each pituitary; and
RPi the sum of points hitting a given target.
Thereafter, the numerical density (NV) of immunohis-
tochemically FSH- and LH-labeled cells was estimated
by physical disector method. Section pairs, that is, two
consecutive sections, designed to be analyzed, were sam-
pled from dorsal, middle and ventral portions of the
pituitary. Four section pairs per pituitary portion (twelve
per pituitary gland) were chosen randomly and immuno-
histochemically stained (Howard and Reed, 2005).
Nuclei of gonadotropic cells were designated as reference
points, and the cells were counted according to the count-
ing rules: (1) if their nuclei appeared within the unbiased
counting frame in the reference section, (2) if they did not
touch forbidden lines of the frame or its extensions and (3)
if they did not appear on the look-up section. The numeri-
cal density was calculated as the number of counted cells
(Q2) contained in the tissue volume that was analyzed
(Vanalyzed). The volume of analyzed tissue was estimated as
a product of the number of counting frames (
P
Pi), area
of counting frame (a5 2,500 mm2) and the disector height
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The number of gonadotropic cells per pars distalis was
calculated as the multiplication product of NV and the
pars distalis volume.
Cells that were counted using the physical disector
were sampled for cell volume estimation by planar rotator
tool as previously described in detail (Manojlovic´-
Stojanoski et al., 2010) and 150–200 FSH- and LH-
immunoreactive cells with nuclei were measured per ani-
mal (objective magnification at 1003). The volume density
(VV) of gonadotropic cells was calculated as the ratio of
the number of points hitting FSH- or LH-immunoreactive
cells and the number of points hitting the reference
space. This parameter was determined on the same sec-
tions that served for NV and cell volume estimation.
Statistical Analysis
All results were expressed as means for six animals
per group6 standard deviation (SD). The data were
tested for normality of distribution by the Kolmogorov–
Smirnov test. One-way analysis of variance followed by
the Newman–Keuls test was used for comparisons of dif-
ferences between the groups. A probability value of 5%
or less was considered as statistically significant.
RESULTS
Histological Analysis
FSH- and LH-immunoreactive cells in pars distalis of
So male pituitaries were oval to polyhedral in shape
with often eccentrically positioned nuclei, and in close
contact with blood capillaries (Fig. 1a,b). Orx caused
hypertrophy of the gonadotropic cells, which were
strongly stained immunohistochemically and often vacu-
olated (Fig. 1c,d). In the pars distalis of Orx males
treated with estradiol, gonadodropic cells were smaller
than those in untreated Orx males, and mostly polyhe-
dral in shape (Fig. 1e,f).
The treatments with both phytoestrogens and soy
extract did not have similar effects to estradiol. The
gonadotropic cells of genistein-treated rats were of simi-
lar size and histological appearance to those of Orx rats
(Fig. 1g,h). After daidzein treatment gonadotropic cells
were slightly smaller in size (Fig. 1i,j), while after
administration of soy extract they had the same morpho-
logical features as untreated Orx males (Fig. 1k,l).
Stereological Analysis
Orchidectomy did not change pars distalis volume (V)
when compared to So males, while treatment with estra-
diol almost doubled its volume (93.2%) in comparison
with the control Orx and So group. Similarly to estra-
diol, but not to the same extent, genistein treatment
increased this parameter by 32.7%. After daidzein and
soy extract administration no change of this parameter
was observed in comparison to the control groups.
After estradiol treatment volume of pars distalis was
twice as those in So males, while after genistein treat-
ment it was increased by 41.9%.
Comparing to the group of Orx males treated with
estradiol, volume of pars distalis was significantly
smaller after treatment with genistein (by 31.3%), daid-
zein (by 47.9%) and soy extract by 31.3, 47.9, and 42.5%,
respectively (Fig. 2a).
In the pituitaries of Orx males, the hypertrophied
gonadotropic cells had significantly increased cellular
volumes (Vc) compared to the So controls, by 81.4% in
the FSH-immunoreactive and 49.9% in the LH-
immunoreactive cells. Treatment with estradiol mark-
edly decreased this parameter by 54.7% for FSH- and
58.8% for LH-labeled cells, respectively, in comparison to
the Orx controls. Volumes of FSH- and LH-labeled cells
were significantly decreased comparing to the So con-
trols, too, by 17.8 and 38.6%, respectively. Comparing
to Orx group, genistein administration did not change
the cellular volume of gonadotropes, while daidzein
decreased the volumes by 15.4 and 14.4% for FSH- and
LH-reactive cells, respectively. No alterations in this
parameter compared to Orx controls were observed in
male Orx rats given soy extract.
Comparing to So controls, volumes of FSH- and LH-
immunoreactive cells were still significantly higher in
the pituitaries of Orx males given genistein, (FSH by
70.8%, LH by 64.9%), daidzein (FSH by 53.4%, LH by
27.9%) and soy extract (FSH by 84.0%, LH by 41.6%)
(Fig. 2b).
When compared to So controls, the volume densities
(VV) of FSH- and LH-reactive cells in the pituitaries of
Orx males were three- and four-fold increased, respec-
tively. Treatment with estradiol returned this parameter
close to the level of So controls. Administration of pure
isoflavones or soy extract did not change the volume
density of FSH-labeled cells compared to Orx control.
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However, the volume density of LH-labeled cells was sig-
nificantly decreased by 22.9% in genistein-treated rats.
Comparing to the So controls, in the pituitaries of Orx
males given genistein, daidzein and soy extract, volume
density of gonadotropic cells was three-fold higher.
Volume density of FSH-immunoreactive cells was
higher after genistein, daidzein and soy extract adminis-
tration by 108.1, 71.1, and 87.9%, respectively, compar-
ing to the Orx males given estradiol. Comparing to the
same group, volume density of LH-immunoreactive cells
was two-fold higher after genistein and soy extract treat-
ment, and three-fold higher following daidzein treatment
(Fig. 2c).
The number of gonadotropic cells per pars distalis
(No) was significantly increased after Orx. Thus, there
were 52.8% more FSH- and 89.6% more LH-labeled cells
than in the So control. Treatment with estradiol addi-
tionally significantly increased the number of FSH-
reactive cells by 41.3% compared to the Orx and two-fold
comparing to the So controls. Numbers of FSH-labeled
cells were also significantly higher after genistein, daid-
zein and soy extract treatment by 90.7, 37.7, and 35.0%,
respectively, than in the Orx control rats. LH-labeled
cells were more abundant in the pituitaries of genistein-
and daidzein-treated animals by 31.5 and 72.1%, respec-
tively, but treatment with soy extract did not affect this
parameter.
Comparing to the So controls, numbers of FSH-
immunoreactive cells were two-fold higher after genis-
tein, daidzein and soy extract treatment. Numbers of
LH-immunoreactive cells were two-fold higher after
genistein and soy extract treatment and three-fold after
daidzein treatment.
No significant changes in the number of gonadotropic
cells was recorded following daidzein and soy extract
treatment when compared to Orx males treated with
estradiol, while the number of FSH-immunoreactive
cells was significantly higher in Orx males treated with
genistein by 35.0% (Fig. 2d).
Numerical density (NV), that is, number of FSH- and
LH-reactive cells per volume unit (mm3) of pars distalis,
in Orx males was 43.2 and 75.8% higher, respectively,
comparing to the So controls. Estradiol treatment low-
ered this parameter significantly, by 27.2% for FSH- and
by 36.2% for LH-labeled cells when compared to the Orx
control group. The numerical density of FSH-reactive
cells was greater after genistein, daidzein and soy
extract treatments by 43.8, 48.5, and 20.5%, respectively.
For LH-reactive cells this parameter was increased only
in the pituitaries of daidzein-treated males (by 29.6%)
comparing to the Orx controls.
Comparing to the So controls, numerical densities of
FSH- and LH-immunoreactive cells were still signifi-
cantly higher after genistein (FSH by 105.9%, LH by
73.3%), daidzein (FSH by 112.7%, LH by 127.7%) and
treatment with soy extract (FSH by 72.6%, LH by
80.5%).
Numerical density of FSH-immunolabeled cells was two-
fold higher in the pituitaries of Orx males given genistein
and daidzein, and by 65.5% higher after soy extract treat-
ment, comparing to the Orx males treated with estradiol.
The same parameter of LH-labeled cells was higher after
genistein, daidzein and soy extract treatment by 54.6,
103.2, and 61.0%, respectively (Fig. 2e).
Fig. 1. Immunohistochemical staining of gonadotropes in the
pituitaries of male rats. Representative micrographs of FSH- (a, c, e,
g, i, k) and LH-immunoreactive (b, d, f, h, j, l) cells in pituitaries of So
(a, b), orchidectomized (Orx) (c, d), Orx rats treated with estradiol
(Orx1E; e, f), genistein (Orx1G; g, h), daidzein (Orx1D; i, j) and soy
extract (Orx1SOY; k, l). In the pituitaries of Orx rats, castration cells
are prominent (c,d), with a vacuolated cytoplasm (arrows). After treat-
ment with estradiol (e, f) the FSH- and LH-labeled cells were smaller
without vacuolated cytoplasm. After genistein (g, h), daidzein (i, j) and
soy extract (k, l) treatments castration cells were still enlarged and
some appeared vacuolated (arrows).
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Fig. 2. Stereological parameters of gonadotropes in the pituitaries of male rats. a—volume of the pars distalis (V; mm3); b—cell volume
(Vc; lm3); c—volume density (VV; %); d—cell number (No); e—numerical density (NV; mm
23) of FSH- and LH-immunoreactive cells in the
pars distalis of sham-operated (So), orchidectomized (Orx), and Orx rats treated with estradiol (Orx1E), genistein (Orx1G), daidzein
(Orx1D) and soy extract (Orx1SOY). All values are provided as the mean6SD; n56. aP< 0.05 vs. So; bP< 0.05 vs. Orx control;
cP< 0.05 vs. Orx1E.
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Immunofluorescence Analysis
Gonadotropic cells of So males gave a strong immuno-
fluorescence signal in the cytoplasm (Fig. 3b). After Orx,
the gonadotropic cells had more pronounced bFSH and
bLH immunofluorescent (IF) signals when compared to
the So group, by 23.1 and 45.3%, respectively. After
estradiol treatment, RIF in both bFSH and bLH contain-
ing cells, was decreased by 29.5 and 30.1%, comparing to
the Orx control group, respectively. No significant
change was noted comparing to the So controls. Signifi-
cantly reduced IF signals from both bFSH and bLH
were noted in gonadotropic cells of genistein, daidzein
and soy extract treated animals, when compared to the
Orx control group. The RIF of bFSH was reduced by
60.4, 50.1, and 50.6%, respectively (Fig. 3a). Within the
cytoplasm of LH-immunoreactive cells, the IF signal was
diminished by 40.1% after treatment with genistein,
41.9% after treatment with daidzein and 50.4% after
treatment with soy extract (Fig. 3a,b).
Fig. 3. Immunofluorescence of gonadotropic cells in the pituitaries of male rats. a—the relative intensity of fluorescence (RIF) of FSH- and LH-
labeled cells in the pituitary pars distalis of sham-operated (So), orchidectomized (Orx), and Orx rats treated with estradiol (Orx1E), genistein
(Orx1G), daidzein (Orx1D) and soy extract (Orx1SOY). All values are provided as the mean6SD; n5 6. aP< 0.05 vs. So; bP< 0.05 vs. Orx con-
trol; cP< 0.05 vs. Orx1E. b—representative micrographs of gonadotropic cells; immunofluorescence for bLH in the pituitary pars distalis of
sham-operated (So), orchidectomized (Orx), and Orx rats treated with estradiol (Orx1E), genistein (Orx1G), daidzein (Orx1D) and soy extract
(Orx1SOY).
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When compared to the So group, RIF of bFSH was
significantly reduced after genistein, daidzein and soy
extract treatment by 51.2, 38.6, and 39.1%, respectively
(Fig. 3a). The RIF signal of bLH was reduced only after
soy extract treatment and by 27.9% (Fig. 3a,b).
Similarly, comparing to the Orx males treated with
estradiol, RIF of bFSH was lower after genistein, daid-
zein and soy extract treatment by 43.8, 29.3, and 29.9%,
respectively (Fig. 3a), while the only significant decrease
of relative bLH IF was noted after soy extract treatment
(by 28.2%) (Fig. 3a,b).
DISCUSSION
In an effort to elucidate whether principal soy isofla-
vones and their combination have an estradiol-like
recovery influence on pituitary castration cells, immuno-
histochemical and morphometric properties of these cells
were assessed after chronic exposure to genistein, daid-
zein and soy extract, and compared to the effects of
estradiol-dipropionate. Our results indicate that the iso-
flavones examined returned intracellular hormone con-
tent to the pre-Orx level, but did not fully reverse the
morphological changes caused by Orx.
In the pituitary pars distalis of adult rats 5 weeks
post Orx, enlarged, often vacuolated and intensely
immunostained gonadotropes were prominent. All mea-
sured stereological parameters and intracellular bFSH
and bLH contents were increased, which indicates
hyperstimulation and formation of castration cells. Hav-
ing in mind that removal of negative feedback control by
gonadal sex steroids causes an increase in intrinsic
GnRH levels released from hypothalamic neurons (Pie-
lecka and Moenter, 2006), and that the same morpholog-
ical changes seen following Orx can be induced by a
synthetic GnRH agonist (Bochimoto et al., 2013), forma-
tion of castration cells is most likely the result of hyper-
stimulation by GnRH. Recovery of castration cells,
therefore, would mostly depend on restoration of GnRH
neuron activity but also partially on regulation of gonad-
otropic cell activity at the pituitary level. Estradiol can
act on both pathways; in the hypothalamus directly on
GnRH neurons via ERb (Temple et al., 2004) and at the
pituitary level via ERa and ERb, since both are present
in gonadotropic cells (Schreihofer et al., 2000). In our
study estradiol treatment led to inhibition of castration
cells, by decreasing intracellular hormone content, vol-
ume and volume density of FSH- and LH-containing
cells to pre-Orx levels. However, the volume of pars dis-
talis and number of gonadotropic cells increased as we
previously reported (Nestorovic´ et al., 2016).
Genistein has been shown to bind to both ERs and
induce ER-mediated estrogenic responses (Kuiper et al.,
1998) and, therefore, it has the potential to suppress
stimulated gonadotropin production. Indeed, we have
found that the relative intensity of the fluorescent sig-
nal, which quantifies intracellular bFSH and bLH pro-
tein content (specific hormonal storage within individual
cells), was returned to the pre-Orx level, or lower, follow-
ing long-term application of genistein. Like estradiol,
genistein increased the volume of pars distalis, which
was probably due to stimulation of prolactin cells (Roma-
nowicz et al., 2004), and increased the number of gonad-
otropic cells. However, the morphology of these
gonadotropic cells was not significantly different from
those in the pituitaries of control Orx males. They were
still enlarged and many of them were vacuolated in
appearance. Additionally, the overall percentage, that is,
volume density, was decreased only in the case of LH-
containing cells and as a result of the slightly greater
volume of pars distalis. Taken together, these results
indicate that genistein showed the same trend of action
as estradiol, but to a much smaller extent. These actions
are probably mediated via ERs pathways. Genistein has
been reported to affect FSH and LH secretion in an
estrogen-like manner in Ovx ewes by acting directly on
the CNS (Romanowicz et al., 2004; Wojcik-Gładysz
et al., 2005, 2006). Having in mind the presence of both
nuclear forms of ERs in the gonadotropic cells
(Schreihofer et al., 2000), it is also possible that genis-
tein acts at the pituitary level as well. Indeed, it has
been shown that it augmented gonadotrope responsive-
ness to the GnRH agonist in an ovine pituitary cell cul-
ture, which was partially reversed by a nuclear ER
antagonist (Arispe et al., 2013). Effects of genistein
through GPER-mediated nongenomic signaling can only
be speculated on, as this pathway is yet to be demon-
strated in the male pituitary (Chimento et al., 2014).
However, a non-ER mediated mechanism of action
should be considered, because genistein treatment
induced differential effects on FSH- and LH-containing
gonadotropic cells. It increased the number of FSH-
containing cells to a much greater extent compared to
LH-containing cells and estradiol treatment. As a known
inhibitor of tyrosine kinase activity and cell cycle pro-
gression (Matsukawa et al., 1993), it is unlikely that the
number of FSH-containing cells increased by prolifera-
tion. On the other hand, sustaining FSH production in a
larger number of gonadotropic cells is a possibility.
Namely, FSH synthesis and secretion are under para-
crine regulation by inhibins, activins and follistatins
(Winters and Moore, 2004). Inhibins act to reduce FSH
secretion; activins stimulate FSH production by gonado-
tropic cells, while follistatins suppress FSH via binding
to and inactivation of activins (Winters and Moore,
2004). By inhibiting tyrosine-kinase, genistein might
have interrupted the pathway of follistatin promoter
activation (Kihara et al., 2006), allowing stimulation of
FSH production by activin.
Daidzein, chronically applied to Orx rats, induced sig-
nificant decreases of intracellular bFSH and bLH pro-
tein content and the volume of FSH- and LH-containing
cells, thus expressing the potential to suppress gonado-
tropin production, like estradiol. Because enlargement of
castration cells mostly originates from expansion of
organelles included in protein synthesis, that is, Golgi
apparatus and rough endoplasmic reticulum (Watanabe
et al., 2014), our results suggest that daidzein inhibited
the synthesis of gonadotropic hormones, but much more
mildly than estradiol. In addition, the volume densities
of gonadotropic cells were decreased, although in the
case of FSH-immunopositive cells the decline did not
reach statistical significance. Daidzein has a very simi-
lar structure to genistein, missing only a single hydroxyl
group. This results in lower binding affinity for ERs
(Kuiper et al., 1998) and little inhibitory effect on tyro-
sine kinase activity (Yokoshiki et al. 1996). Therefore, it
is not surprising that daidzein did not act in the same
way as genistein on the volume of pituitary pars dista-
lis, and the number of FSH-containing cells.
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The combination of genistein and daidzein, applied in
the form of soy extract had no effect on the morphologi-
cal features of LH-labeled cells. It enhanced the number
and numerical density of FSH-containing cells, without
affecting cell volume and volume density. This is proba-
bly due to the slight increase in volume of pars distalis
that did not reach statistical significance. However, sig-
nificant reductions of intracellular bFSH and bLH con-
tent were recorded. The changes induced by soy extract
were in the same direction as those caused by genistein,
but less strong. Thus, it can be assumed that soy extract
has little potential to affect FSH and LH production.
In our study the purified isoflavones, genistein and
daidzein, and their combination in soy extract signifi-
cantly decreased intracellular hormone content but other
morphological indicators of recovery of castration cells
were not as apparent. The increase in number of still
enlarged gonadotropic cells suggests that the physiologi-
cal endpoint, that is, suppression of gonadotropin
production, was probably not achieved by soy phytoestro-
gens, even when the reduced intracellular hormone con-
tent was taken into account. Therefore, it can be
concluded that soy phytoestrogens do not fully reverse
the changes in pituitary castration cells.
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